Viewing Study NCT07414667


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 5:35 AM
Study NCT ID: NCT07414667
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-17
First Post: 2025-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)
Sponsor: Central Hospital, Nancy, France
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module